Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Mar 20:11:151.
doi: 10.3389/fendo.2020.00151. eCollection 2020.

Commentary: The Development of Gonadotropins for Clinical Use in the Treatment of Infertility

Affiliations
Comment

Commentary: The Development of Gonadotropins for Clinical Use in the Treatment of Infertility

Fabiola Beligotti. Front Endocrinol (Lausanne). .
No abstract available

Keywords: assisted reproductive technologies (ART); follicle stimulating hormone (FSH); follitropin delta; human menopausal gonadotrophin (hMG); ovarian stimulation.

PubMed Disclaimer

Comment on

References

    1. Nyboe Andersen A, Nelson SM, Fauser BCJM, García-Velasco JA, Klein BM, Arce J-C, et al. Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial. Fertil Steril. (2017) 107:387–96.e4. 10.1016/j.fertnstert.2016.10.033 - DOI - PubMed
    1. European Medicines Agency Rekovelle: Follitropin Delta. (2017). Available online at: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medici... (accessed August 20, 2019).
    1. Therapeutic Goods Administration (TGA) Commonwealth of Australia Australian Public Assessment Report (AusPAR) Rekovelle (2017). Available online at: https://www.tga.gov.au/sites/default/files/auspar-follitropin-delta-rhu-... (accessed March 29, 2019).
    1. Humaidan P, Chin W, Rogoff D, D'Hooghe T, Longobardi S, Hubbard J, et al. Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders. Hum Reprod. (2017) 32:1537–8. 10.1093/humrep/dex208 - DOI - PMC - PubMed
    1. Humaidan P, Chin W, Rogoff D, D'Hooghe T, Longobardi S, Hubbard J, et al. Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders. Hum Reprod. (2017) 32:544–55. 10.1093/humrep/dew360 - DOI - PMC - PubMed

Publication types

LinkOut - more resources